GeneDx Study Finds 62% of Patients With Pathogenic or Likely Pathogenic Findings Have Medically Actionable Results

• GeneDx announced research on exome and genome sequencing results from more than 300,000 patients, highlighting potential clinical benefits beyond diagnosis.
• Findings showed that genetic results could help guide treatment, disease surveillance and long-term care for patients with pathogenic or likely pathogenic findings.
• Results will be presented at the National Society of Genetic Counselors annual conference, Nov. 11-14, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261110972518) on November 10, 2026, and is solely responsible for the information contained therein.